Results from a study published in the Journal of Internal Medicine suggest that bacterial infections may elevate the risk of coronary heart disease in individuals with type 1 diabetes.
Among 3,781 individuals with type 1 diabetes, 370 developed coronary heart disease over an average follow-up of 13.7 years. Antibiotic purchases, reflecting bacterial infections in outpatient care, were significant risk factors for coronary heart disease, with a 21% increased risk for each annual antibiotic purchase.
A high blood level of bacterial lipopolysaccharides (large molecules derived from the outer layer of gram-negative bacteria) was also a risk factor for coronary heart disease.
“In broader terms, the present study demonstrates how infections associate with the development of late diabetic complications and perhaps even more importantly, how infections associate with the development of coronary heart disease, as the latter relationship has been disputed during recent years,” said lead author Johan Rasmus Simonsen, MD, of the Folkhälsan Research Center, in Finland. “Interestingly, in our study this association to incident coronary heart disease was seen specifically with antibiotic purchases, making the potential pathophysiologic mechanisms behind this finding intriguing and warranting further studies.”
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/joim.13138
About Journal
Journal of Internal Medicine (JIM), with its International Advisory Board, has developed into a highly successful journal since it was launched in its revised form in 1989. With an Impact Factor of 6.871, Journal of Internal Medicine now ranks 14th among the 165 journals in the General & Internal Medicine category.
- Established in 1863.
- Features original clinical articles within the broad field of general and internal medicine and its sub-specialties.
- A fully international journal publishing articles in English from all over the world.
- Peer-reviewed and published in both print and online versions.
JIM also supports and organizes scientific meetings in the form of symposia within the scope of the journal.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.